Related Experiment Video
Updated: Sep 20, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
Zhenyu Nie1, Mei Chen1, Yuanhui Gao1
1Central Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.
Abstract:
Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Considering to the important role of chemotherapy in tumor treatment, drug resistance has become the most serious challenge. Revealing the molecular mechanism of ferroptosis is expected to solve tumor drug resistance and find new therapies to treat cancers. In this review, we discuss the relationship between ferroptosis and tumor drug resistance, summarize the abnormal ferroptosis in tissues of different cancer types and current research progress and challenges in overcoming treatment resistance, and explore the concept of targeting ferroptosis to improve tumor treatment outcomes.
Insights
Ferroptosis, a unique cell death process, impacts cancer development and treatment. Understanding its role may overcome drug resistance and lead to new cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ferroptosis is a regulated cell death characterized by iron accumulation and lipid peroxidation.
- Its metabolic features are crucial for evaluating disease states, particularly in tumors.
- Ferroptosis influences tumor progression, metastasis, and response to therapies.
Purpose of the Study:
- To review the intricate relationship between ferroptosis and cancer drug resistance.
- To summarize current knowledge on aberrant ferroptosis in various cancer types.
- To explore strategies targeting ferroptosis for improved cancer treatment outcomes.
Main Methods:
- Literature review of studies on ferroptosis and cancer.
- Analysis of molecular mechanisms linking ferroptosis to drug resistance.
- Synthesis of research progress and challenges in overcoming treatment resistance.
Main Results:
- Ferroptosis plays a significant role in regulating tumor development, metastasis, and therapeutic responses.
- Drug resistance remains a major challenge in cancer chemotherapy.
- Aberrant ferroptosis is observed across different cancer types, contributing to treatment failure.
Conclusions:
- Targeting ferroptosis presents a promising strategy to overcome cancer drug resistance.
- Further research into ferroptosis mechanisms can unveil novel therapeutic targets for cancer treatment.
- Understanding and manipulating ferroptosis is key to improving patient outcomes in oncology.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Drugs that Stabilize Microtubules